References
- AnthenelliRMRecent advances in the treatment of tobacco dependenceClinical Neuroscience Research20055175183
- BalerioGNAsoEMaldonadoRRole of cannabinoid system in the effects induced by nicotine on anxiety-like behavior in micePsychopharmacology20061845041316416159
- BlondalTGudmundssonLJOlafsdottirINicotine nasal spray with nicotine patch for smoking cessation: a randomized trail with six year follow-upBMJ199931828599924052
- BohadanaANilssonFRasmussenTNicotine Inhaler and Nicotine Patch as a Combination Therapy for Smoking CessationArch Intern Med200016031283411074742
- CohenCPerraultGGriebelGNicotine-associated cues maintain nicotine-seeking behavior in rats several weeks after nicotine withdrawal; reversal by the cannabinoid (CB1) receptor antagonist, rimonabant (SR141716)Neuropsychopharmacology2005301455515292905
- DaleLCAnthenelliRMRimonabant as an aid to smoking cessation in smokers motivated to quit: results from a U.S. Multicenter Study–STRATUS U.S. Trial2004Abstract presented at the Annual Meeting of the American College of Cardiology
- DespresJPGolayASjostromLEffects of rimonabant on metabolic risk factors in overweight patients with dyslipidemiaN Engl J Med200535321213416291982
- FagerstromKBalfourDJNeuropharmacology and potential efficacy of new treatments for tobacco dependenceExpert Opin Investig Drugs20061510716
- FioreMCBaileyWCCohenSJTreating Tobacco Use and Dependence: Clinical Practice Guideline2000Rockville, MDUS Department of Health and Human Services. Public Health Service
- GelfandEVCannonCPRimonabant: a cannabinoid receptor type 1 blocker for management of multiple cardiometabolic risk factorsJ Am Coll Cardiol20064719192616697306
- GonzalesDRennardSINidesMVarenicline, an α4β2 nicotinic acetylcholine receptor partial agonist, vs sustained-release bupropion and placebo for smoking cessation: a randomized controlled trialJAMA2006296475516820546
- HenningfieldJEFantRVBuchhalterARPharmacotherapy for nicotine dependenceCA Cancer J Clin2005552819916166074
- HughesJRGoldsteinMGHurtRDRecent Advances in Pharmacotherapy of SmokingJAMA199928172769892454
- HughesJSteadLLancasterTAntidepressants for smoking cessationCochrane Database Syst Rev20044CD00003115494986
- JorenbyDELeischowSJA Controlled Trial of Sustained-Release Bupropion, a Nicotine Patch, or Both for Smoking CessationN Engl J Med199934068569110053177
- JorenbyDEHaysJTRigottiNAEfficacy of varenicline, an α4β2 nicotinic acetylcholine receptor partial agonist, vs placebo or sustained-release bupropion for smoking cessation: a randomized controlled trialJAMA2006296566316820547
- KelleyAENicotine receptors: addiction’s smoking gun?Nat Med200231447911984581
- NiauraRLong-term treatment with rimonabant for smoking cessation and the maintenance of abstinence: results from STRATUS-Worldwide trial2005Abstract presented at the Society for Research on Nicotine and Tobacco Annual Conference
- SilagyCLancasterTSteadLNicotine replacement therapy for smoking cessationCochrane Database Syst Rev20043CD00014615266423
- SteinbergMBFouldsJRichardsonDLPharmacotherapy and smoking cessation at a tobacco dependence clinicPrev Med200642114916375954
- TonstadSTonnesenPHajekPEffect of maintenance therapy with varenicline on smoking cessationJAMA2006296647116820548
- US Department of Health and Human ServicesThe Consequences of Smoking: A Report of the Surgeon General. US Department of Health and Human Services, Centers for Disease Control and Prevention, National Center for Chronic Disease Prevention and Health Promotion, Office on Smoking and Health
- VanGaalLFRissanenAMScheenAJEffects of the cannabinoid-1 receptor blocker rimonabant on weight reduction and cardiovascular risk factors in overweight patients: 1-year experience from the RIO-Europe studyLancet200536513899715836887
- WarnerCShoaibMHow does bupropion work as a smoking cessation aid?Addict Biol2005102193116109583